StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BofA Securities Comments on Novo Nordisk (NVO)
May 3, 2024 5:55 AM
BofA Securities analyst Sachin Jain reiterated a Buy rating and $147.00 price target on Novo Nordisk (NYSE: NVO)The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Buy the dip in this major pharma stock - Citi
May 6, 2024 9:30 AM
Form 6-K NOVO NORDISK A S For: Mar 31
May 2, 2024 7:17 AM
Novo Nordisk (NVO) sales jump on strong demand for obesity drug
May 2, 2024 6:23 AM
European stocks mixed; Shell shines as quarterly earnings continue
May 2, 2024 5:55 AM
Novo Nordisk (NVO) Reports Q1 EPS of DKK5.68; updates guidance
May 2, 2024 5:10 AM
Novo Nordisk (NVO) call put ratio 2.8 calls to 1 put into quarter results
May 2, 2024 2:48 AM
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
May 2, 2024 1:34 AM
Novo Nordisk (NVO) May weekly option implied volatility into quarter results
May 1, 2024 10:29 AM
Form 6-K NOVO NORDISK A S For: May 01
May 1, 2024 9:06 AM
Follow-Up Drilling to Commence at Nunyerry North and New Targets Defined Near Karratha
May 1, 2024 8:58 AM
Novo Nordisk (NVO) May weekly 128 straddle priced into quarter results
May 1, 2024 5:15 AM
